Tonix Breaks Ground on Biopharma Facility in Hamilton, Montana
1 report, 1 independent
Updated Oct 8
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Tonix, a New Jersey based company, broke ground on a new biopharmaceutical facility in Hamilton, Montana, on October 8, 2026. The facility is designed to manufacture TNX-4800, a long-acting monoclonal antibody intended to prevent the transmission of Lyme disease. The construction is expected to occur in phases.
From nbcmontana.com
Why it matters
The facility aims to advance drug development and manufacturing efforts within the Bitterroot Valley bio tech corridor. The antibody, TNX-4800, is intended to prevent the transmission of a bacterial infection, though it is not a vaccine.
Tonix is a New Jersey based company.
From nbcmontana.com
Who's involved
- New JerseyState where Tonix is based
- HamiltonCity where the new biopharmaceutical facility is being built
- Rocky Mountain LaboratoriesInstitution whose scientist discovered the pathogen responsible for Lyme Disease